Clinical trial Recruiting at 1 site Interventional Ages 18 to 45

Cardiac rehabilitation for young cancer survivors

Official title: The Harmonized Interventions to Maintain Health Via Appropriate Risk Factor Modification and Lifestyle Changes in Pediatric, Adolescent and Young Adult Cancer Survivors Study: A Multicentre Randomized Controlled Trial

Run by University Health Network, Toronto · NCT05023785 · Data updated 2026-11-12

This study tests a special exercise program for young cancer survivors to see if it can help improve their heart health and overall fitness.

More Heart Failure trials

Quick facts

Study typeInterventional
Ages18 Years to 45 Years
SexAll
Enrollment336 (estimated)
SponsorUniversity Health Network, Toronto
Academic / other
Drugs / interventionstrastuzumab
Locations1 site (Toronto, Ontario)
StatusRecruiting
StartedJanuary 1, 2024
Main results expectedSeptember 2026
Study endsMarch 2027
Registry record updatedNovember 26, 2025
Trial IDNCT05023785 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates are cancer survivors aged 18-45 who were diagnosed with cancer before age 40 and have experienced treatment-related cardiovascular risks.

Probably not a fit

Patients who are currently undergoing cancer treatment or those with advanced heart failure may not benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This trial evaluates the effectiveness of a Cardio-Oncology Rehabilitation (CORE) program for pediatric, adolescent, and young adult cancer survivors who are at increased risk of cardiovascular issues due to their cancer treatments. Participants will engage in a six-month structured exercise program that includes both home and onsite training, aimed at improving their cardiovascular health and overall fitness. The study will assess changes in physical fitness, cardiac function, and psychosocial well-being among participants. By focusing on non-pharmacological interventions, this trial seeks to address the unique health challenges faced by this underserved population.

Why it matters

Potential benefit: If successful, this intervention could significantly improve cardiovascular health and quality of life for young cancer survivors.

How similar studies have gone: Previous studies have shown promise in using exercise and rehabilitation programs for improving cardiovascular outcomes in cancer survivors, indicating that this approach is both relevant and potentially effective.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

1. Be a PAYA-CS, defined as ≤39 years of age at the time of cancer diagnosis;
2. Be 18-45 years of age at the time of enrolment;
3. Received cancer treatment(s) with known cardiovascular risks (e.g., anthracyclines, trastuzumab, radiotherapy, platinum-based agents, vascular endothelial growth factor inhibitors, tyrosine kinase inhibitors);
4. Be cancer-free at the time of enrollment;
5. Stage B Heart Failure (SBHF)

   * In patients with availability of pre-treatment imaging:

     * ≥10% decrease in LVEF at post-treatment compared to pre-treatment
     * ≥15% decrease in GLS at post-treatment compared to pre-treatment
   * No pre-treatment imaging:

     * LVEF ≤53% in women/51% in men
     * GLS \>-18%
     * Left ventricular hypertrophy (LV mass/body surface area: \>95 g/m2 for women or \>115 g/m2 for men)
     * Concentric remodelling (\>0.42 relative wall thickness)
     * Diastolic dysfunction (≥ grade 1)
     * BNP ≥35pg/ml or NT-proBNP ≥125pg/ml

Exclusion Criteria:

1. Have an absolute or unresolved relative contraindication to exercise according to the American College of Sports Medicine guidelines;
2. Have an untreated physical or mental health concern that precludes safe and effective exercise participation;
3. Have established CVD (excluding mildly reduced LVEF as described above);
4. Be pregnant at time of recruitment;
5. Be currently engaging in frequent high-intensity exercise (\>1 high-intensity exercise session per week);
6. Have substantial barriers to participating, including (1) living too far from study centre or (2) being unable or willing to comply with the study protocol.

Where it's running

  • University Health Network
    Toronto, Ontario, Canada
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.